Cary Street Partners Investment Advisory LLC Haemonetics Corp Transaction History
Cary Street Partners Investment Advisory LLC
- $173 Billion
- Q1 2025
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 17 shares of HAE stock, worth $1,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17Holding current value
$1,271% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$446 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$381 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$325 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$196 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$164 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.84B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...